At 21 months, ChAd/BNT vaccination also elicited enhanced memory B-cell responses (IgM−/IgG+ phenotype) and stronger CD8+ T-cell cytokine production, especially in individuals with hybrid immunity from prior infection [16]. Here, CD8A is linked to infection.